COINFECÇÃO COM Staphylococcus aureus COMO AGRAVANTE DA COVID-19
DOI:
10.46551/ruc.v23n1a03Palabras clave:
Coinfecção. Staphylococcus aureus. COVID-19. AntibióticosResumen
Objetivo: investigar índices de ocorrência de coinfecção Staphylococcus aureus e SARSCoV-2 e discutir o uso de antimicrobianos durante a pandemia COVID-19. Métodos: Trata-se de uma revisão integrativa de literatura com busca de artigos na base de dados médicos internacional PubMed, com a produção de um fluxograma que inclui identificação, seleção e inclusão dos dados. Resultados: Os dados de coinfecção com S. aureus em pacientes COVID-19 são ainda escassos, todavia atentam
para uma taxa de coinfecção baixa. Embora os índices estatísticos sejam baixos, quando esse tipo de coinfecção se faz presente, resulta em agravamento da COVID-19 elevando a chance de letalidade. Suspeitas de coinfecções levam ao uso de antibióticos, muitas vezes de forma empírica, o que pode favorecer o aumento da seleção de bactérias resistentes, sendo este último ponto um problema grave de saúde pública mundial. Considerações finais: A partir da situação atual, é imperativo aconselhar o uso racional de antimicrobianos, mediante critérios clínico-epidemiológicos, rastreio laboratorial e teste de sensibilidade aos antimicrobianos. Tais parâmetros asseguram o correto tratamento, controlam a seleção de cepas multirresistentes e auxiliam na segurança do paciente.
Descargas
Citas
ZU, Z. Y. et al. Coronavirus Disease 2019 (COVID-19): A Perspective from China.
Radiology, Oak Brook, v. 296, n. 2, ago. 2020. Disponível em:
<http://pubs.rsna.org/doi/10.1148/radiol.2020200490>. Acesso em: 06 Abr. 2021.
TRINDADE, G. G. et al. COVID-19: therapeutic approaches description and
discussion. Anais da Academia Brasileira de Ciências, Rio de Janeiro, v. 92, n. 2,
maio. 2020. Disponível
em:<http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-
&tlng=en>. Acesso em: 12 Maio 2021.
JIN, Y. et al. Virology, epidemiology, pathogenesis, and control of covid-19. Viruses,
Basel, v. 12, n. 4, p. 2–17, mar, 2020.
CHEN, G. et al. Clinical and immunological features of severe and moderate
coronavirus disease 2019. Journal of Clinical Investigation, New York, v. 130, n. 5,
p. 2620–2629, mar, 2020.
TAY M. Z. et al. The trinity of COVID-19: immunity, inflammation and intervention.
Nature Reviews Immunology, London, v. 20, n. 6, abr. 2020. Disponível
em:<http://dx.doi.org/10.1038/s41577-020-0311-8>. Acesso em: 06 Abr. 2021.
SHARIFIPOUR E. et al. Evaluation of bacterial co-infections of the respiratory tract in
COVID-19 patients admitted to ICU. BMC Infectious Diseases, London, v. 20, n. 1, p.
–7, set, 2020.
DANDAGI G. L. Nosocomial pneumonia in critically ill patients. Lung India, Mumbai,
v. 27, n. 3, p. 149–153, Jul-Set, 2010.
FATTORINI L. et al. Bacterial coinfections in COVID-19: an underestimated
adversary. Annali dell'Istituto superiore di sanita, Roma, v. 56, n. 3, jul. 2020.
Disponível em:<http://www.ncbi.nlm.nih.gov/pubmed/32959802>. Acesso em: 06
Abr. 2021.
VAN BELKUM A. et al. Reclassification of staphylococcus aureus nasal carriage
types. Journal of Infectious Diseases, Chicago, v. 199, n. 12, p. 1820-1826, maio,
WERTHEIM H. F. L. et al. The role of nasal carriage in Staphylococcus aureus
infections. Lancet Infectious Diseases, London, v. 5, n. 12, p. 751–762, dez, 2005.
MULCAHY M. E. et al. Staphylococcus aureus and influenza a virus: Partners in
coinfection. mBio, Washington, v. 7, n. 6, p. 4–7, dez, 2016.
OPATOWSKI L. et al. Influenza interaction with cocirculating pathogens and its
impact on surveillance, pathogenesis, and epidemic profile: A key role for
mathematical modelling. PLOS Pathogens, San Francisco, v. 14, n. 2, fev. 2018.
Disponível em:<https://dx.plos.org/10.1371/journal.ppat.1006770>. Acesso em: 08
Abr. 2021.
TASHER D. et al. Invasive bacterial infections in relation to influenza outbreaks,
-2010. Clinical Infectious Diseases, Chicago, v. 53, n. 12, p. 1199–1207, out,
WANG J. H. et al. Rhinovirus enhances various bacterial adhesions to nasal epithelial
cells simultaneously. Laryngoscope. Hoboken, v. 119, n. 7, p. 1406–1411, mar, 2009.
ALMAND E. A. et al. Virus-bacteria interactions: An emerging topic in human
infection. Viruses, Basel, v. 9, n. 3, p. 1–10, mar, 2017.
MIRZAEI R. et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life, Oxford, v.
, n. 10, p. 2097–2111, jul, 2020.
CHERTOW D. S. et al. Bacterial coinfection in influenza: A grand rounds review.
JAMA - Journal of the American Medical Association, Chicago, v. 309, n. 3, p. 275–
, jan, 2013.
BENGOECHEA JA, Bamford CG. SARS-CoV-2, bacterial co-infections, and AMR:
the deadly trio in COVID-19?. EMBO Molecular Medicine, New Jersey, v. 12, n. 7, p.
–13, jun, 2020.
ZHOU F. et al. Clinical course and risk factors for mortality of adult inpatients with
COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, London, v.
, n. 10229, mar. 2020. Disponível em:
<https://linkinghub.elsevier.com/retrieve/pii/S0140673620305663>. Acesso em: 08
Abr. 2021.
RAMADAN H. K-A. et al. Predictors of Severity and Co-Infection Resistance Profile
in COVID-19 Patients: First Report from Upper Egypt. Infection and drug resistance,
Auckland, v. 13, out. 2020. Disponível em:
<http://www.ncbi.nlm.nih.gov/pubmed/33116660>. Acesso em: 06 Abr. 2021.
RAWSON T. M. et al. Bacterial and Fungal Coinfection in Individuals With
Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
Antimicrobial Prescribing. Clinical infectious diseases: an official publication of the
Infectious Diseases Society of America, Chicago, v. 71, n. 9, out. 2020. Disponível
em:<https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa530/5828058>.
Acesso em: 06 Abr. 2021.
LANGFORD B. J. et al. Bacterial co-infection and secondary infection in patients
with COVID-19: a living rapid review and meta-analysis. Clinical Microbiology and
Infection, Oxford, v. 26, n. 12, dez. 2020. Disponível em:
<https://linkinghub.elsevier.com/retrieve/pii/S1198743X20304237>. Acesso em: 06
Abr. 2021.
LANSBURY L. et al. Co-infections in people with COVID-19 : a systematic review
and. Journal of Infection, London, v. 81, n. 2, maio 2020. Disponível em:
<https://doi.org/10.1016/j.jinf.2020.05.046>. Acesso em: 06 Abr. 2021.
CUSUMANO J. A. et al. Staphylococcus aureus Bacteremia in Patients Infected with
COVID-19: A Case Series. Open Forum Infectious Diseases, Cary, v. 7, n. 11, p. 5–
, 2020.
CROTTY M. P. et al. Investigation of subsequent and co-infections associated with
SARS-CoV-2 ( COVID-19 ) in hospitalized patients. medRxiv, v. 2, p. 1–19, jun.
ELABBADI A. et al. Bacterial coinfection in critically ill COVID-19 patients with
severe pneumonia. Infection, Munich, v. 49, n. 3, nov. 2020. Disponível em:
<https://doi.org/10.1007/s15010-020-01553-x>. Acesso em: 08 Abr. 2021.
CONTOU D. et al. Bacterial and viral co-infections in patients with severe SARSCoV-2 pneumonia admitted to a French ICU. Annals of Intensive Care, Paris, v. 10, n.
, set. 2020. Disponivel em:<https://doi.org/10.1186/s13613-020-00736-x>. Acesso
em: 08 Abr. 2021.
DUPLOYEZ C. et al. Panton-Valentine Leukocidin–Secreting Staphylococcus aureus
Pneumonia Complicating COVID-19. Emerging Infectious Diseases, Atlanta, v. 26, n.
, ago. 2020. Disponível em:<http://wwwnc.cdc.gov/eid/article/26/8/20-
_article.htm>. Acesso em: 06 Abr. 2021.
MAHMOUDI H. Bacterial co-infections and antibiotic resistance in patients with
COVID-19. GMS hygiene and infection control, Berlin, v. 15, dez. 2020. Disponível
em:<http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC7747008>.
Acesso em: 06 Abr. 2021.
GARCIA-VIDAL C. et al. Incidence of co-infections and superinfections in
hospitalized patients with COVID-19: a retrospective cohort study. Clinical
Microbiology and Infection, Oxford, v. 27, n. 1, Jul. 2020. Disponível
em:<https://linkinghub.elsevier.com/retrieve/pii/S1198743X2030450X>. Acesso em:
Abr. 2021.
ADEIZA S. S. et al. Random Effects Meta-Analysis of COVID-19/S. Aureus
Partnership in Co-Infection. SSRN Electronic Journal, New York, v. 15, p. 1–10, nov.
HUANG C. et al. Clinical features of patients infected with 2019 novel coronavirus in
Wuhan, China. The Lancet, London, v. 395, n. 10223, fev. 2020. Disponível
em:<https://linkinghub.elsevier.com/retrieve/pii/S0140673620301835>. Acesso em:
Abr. 2021.
LI J. et al. Etiology and antimicrobial resistance of secondary bacterial infections in
patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis.
Antimicrobial Resistance and Infection Control, London, v. 9, n. 1, p. 1–7, set. 2020.
YAP F. H. Y. et al. Increase in methicillin-resistant Staphylococcus aureus acquisition
rate and change in pathogen pattern associated with an outbreak of severe acute
respiratory syndrome. Clinical Infectious Diseases, Chicago, v. 39, n. 4, p. 511–516,
ago. 2004.
WHO. Global action plan on antimicrobial resistance [Internet]. World Health
Organization, editor. World Health Organization. World Health Organization; 2015. p.
–28. Disponível em:<https://www.who.int/publications/i/item/9789241509763>.
Acesso em: 10 Maio 2021.
DONÀ D. et al. Multi-drug-resistant infections in the COVID-19 era: a framework for
considering the potential impact. Journal of Hospital Infection, Burlington, v. 106, n.
, Maio 2020. Disponível
em:<https://linkinghub.elsevier.com/retrieve/pii/S0195670120302516>. Acesso em:
Abr. 2021.
HUGHES S. et al. Bacterial and fungal coinfection among hospitalized patients with
COVID-19: a retrospective cohort study in a UK secondary-care setting. Clinical
Microbiology and Infection, Oxford, v. 26, n. 10, out. 2020. Disponível em:
<https://linkinghub.elsevier.com/retrieve/pii/S1198743X20303694>. Acesso em: 08
Abr. 2021.
LAI C-C. et al. Co-infections among patients with COVID-19: The need for
combination therapy with non-anti-SARS-CoV-2 agents? Immunology and Infection, Hong Kong, v. 53, n. 4, ago. 2020. Disponível
em:<https://linkinghub.elsevier.com/retrieve/pii/S1684118220301274>. Acesso em:
Abr. 2021.
HUTTNER B. D. et al. COVID-19: don’t neglect antimicrobial stewardship
principles! Clinical Microbiology and Infection, Oxford, v. 26, n. 7, abr. 2020.
Disponível em:<https://doi.org/10.1016/j.cmi.2020.04.024>. Acesso em: 10 Maio
CLANCY C. J. et al. Bacterial Superinfections Among Persons With Coronavirus
Disease 2019: A Comprehensive Review of Data From Postmortem Studies. Open
Forum Infectious Diseases, Cary, v. 8, n. 3, fev. 2021.
RANDALL M. et al. Nosocomial methicillin-resistant Staphylococcus aureus
bacteremia in incarcerated patients with severe COVID-19 infection. American
Journal of Infection Control, Saint Louis, v. 48, n. 12, dez. 2020. Disponível
em:<https://doi.org/10.1016/j.ajic.2020.09.005>. Acesso em: 06 Abr. 2021.
PUNJABI C. et al. Prevalence of MRSA in Respiratory cultures and Diagnostic
Performance of the MRSA Nasal PCR in Patients hospitalized with COVID-19
Pneumonia. Infection Control and Hospital Epidemiology, Chicago, v. 2019, p. 1–2,
ago. 2020.
SPOTO S. et al. A staphylococcus aureus coinfection on a COVID-19 pneumonia in a
breast cancer patient. International Journal of General Medicine, Auckland, v. 13, p.
–733, set. 2020.
